Cart
sales@molnova.com
Baminercept
CAS No. 909110-25-4
Baminercept( —— )
Catalog No. M37168 CAS No. 909110-25-4
Baminercept (BG 9924) is a lymphotoxin-β receptor-immunoglobulin fusion protein that blocks the lymphotoxin-alphabets/LIGHT axis, and is used to study primary desiccation syndrome (SS) with rheumatoid arthritis (RA).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1017 | In Stock |
|
| 10MG | 1634 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBaminercept
-
NoteResearch use only, not for human use.
-
Brief DescriptionBaminercept (BG 9924) is a lymphotoxin-β receptor-immunoglobulin fusion protein that blocks the lymphotoxin-alphabets/LIGHT axis, and is used to study primary desiccation syndrome (SS) with rheumatoid arthritis (RA).
-
DescriptionBaminercept (BG 9924) is a lymphotoxin β receptor IgG fusion protein (LTβR-Ig). Baminercept can be used for the research of many autoimmune diseases including primary Sj gren's syndrome (SS) and rheumatoid arthritis (RA) .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number909110-25-4
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. E William St Clair, et al. Clinical Efficacy and Safety of Baminercept, a Lymphotoxin β Receptor Fusion Protein, in Primary Sj?gren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol. 2018 Sep;70(9):1470-1480.?
molnova catalog
related products
-
Triptophenolide
Triptophenolide is a compound isolated from?Tripterygium wilfordii Hook with anti-inflammatory activity.
-
dihydrocarveol
dihydrocarveol is?Fragrance material.
-
Sarmenoside II
Sarmenoside II is a flavonol glycoside with activity that inhibits lipid accumulation. Sarmenoside II inhibits albumin-oleate-induced lipid accumulation in HepG2 cells by approximately 30% at 100 μM.
